Simultaneous determination of prazosin, atorvastatin, rosuvastatin and simvastatin in API, dosage formulations and human serum by RP-HPLC

Journal of the Chinese Chemical Society

Volumn 57, Issue 6, 2010, Pages 1286-1292

  Sultana, Najma ^a   Arayne, M Saeed ^a   Shah, Shabana Naz ^b   Shafi, Nighat ^b   Naveed, Safila ^c  

^a United Biotechnologies   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

^c HAMDARD UNIVERSITY   (Pakistan)

Author keywords

Atorvastatin; Prazosin; Rosuvastatin and simvastatin; RP HPLC

Indexed keywords

EID: 79952094915     PISSN: 00094536     EISSN: None     Source Type: Journal    
DOI: 10.1002/jccs.201000190     Document Type: Article

References (40)

1. Cannon, C. P.; Braunwald, E.; McCabe, C. H. et al. N. Engl. J. Med., 2004,350, 1495-1504.
2. Colhoun, H. M.; Betteridge, D. J.; Durrington, P. N. et al. The Lancet 2004, 364, 685-96.
3. Pedersen, T. R.; Faergeman, O.; Kastelein, J. J. et al. JAMA. 2005, 294, 2437-45.
4. Kostek, J. L. Anal. Profiles Drug Subst. 1989, 18, 351.
5. Levine, T. B. Am. J. Cardiol. 1985, 55, 32-35.
6. Reich, J. W.; Gennaro, A. R. Remington, The Science and Practice of Pharmacy, 20th ed.; Mack Publishing Company: Easton, PA, 2000; Vol. II, p 1294.
7. Be-Dell, S. L. The Complete Drug Reference; Mosby-Year Book, Inc.: St. Louis, MO, 1996; p 1887.
8. Scandinavian, Simvastatin Survival Study Group. The Lancet 1994, 344, 1383-89.
9. O'Neil, M. J. The Merck Index. An Encyclopedia of Chemicals, Drugs and Biologicals, 14th ed.; Merck & Co., Inc.: Whitehouse Station, NJ, 2006; p 1471.
10. Gould, K. L.; Casscells, S. W.; Buja, L. M.; Goff, D. C. The Lancet 1995, 346, 750-753.
11. Shepherd, J. Am. J. Cardiol. 1998, 82, 57T-59T.
12. Shinichiro, N.; Hiroshi, W.; Kazuhiro, K.; Shinya, U.; Hideharu, H.; Kyoichi, O. Hypertension Res. 2005, 28, 223-227.
13. Antonio, M. G. Jr.; Dphill, M. D. Am. J. Med. 2002, 112(8), 10-18.
14. Robert, A. K.; Albert, O. J. Clin. Endocrinol. Metab. 2002, 87(2), 423-437.
15. Michael, O. R. Lower Coronary Event Rates in Patients Treated with Amlodipine and Atorvastatin; Hypertension Medscape, Medical News, 2005.
16. Sever, P. On behalf of the ASCOT investigators. ASCOTLLA Revisited: Interaction of Antihypertensive and Lipidlowering Therapy. American Heart Association Scientific Sessions, 2005, November 14, Dallas, TX.
17. Hiroshi, W.; Kazuhiro, K.; Shinichiro, N.; Hiroshi, Y.; Shinya, U.; Hiroshi, S.; Hideharu, H.; Takashi, I.; Kyoichi, O. Life Sci. 2004, 76(3), 281-292.
18. Pan, H. Y.; Triscari, J.; De-Vault, A. R.; Smith, S. A.; Wang, I. D.; Swanson, B. N.;Willard, D. A. Br. J. Clin. Pharmacol. 1991, 31, 665-670.
19. Mohammed, M. E.; Aboul-Enein, Y. H. Pharmazie 1985, 40, 358.
20. United States Pharmacopeia 26 (USP 26), United States Pharmacopeia Convention, Rockville, 2002.
21. Monika, B.; Tina, O.; Saranjit, S. J. Pharm. Biomed. Anal. 2004, 34(1), 19-26.
22. Ozgur, M. U.; Sungur, S. Turkish J. Chem. 2002, 26, 691-696.
23. Hye-Sun, G.; In-Koo, C. J. Appl. Pharm. 2005, 13(2), 90.
24. Araye, M. S.; Sultana, N.; Hussain, F.; Ali, S. A. J. Anal. Chem. 2007, 62(6), 536-541.
25. Abu-Nameh, E. S. M.; Shawabkeh, R. A.; Ali, A. J. Anal. Chem. 2006, 61, 63-66.
26. Wang, L.; Asgharnejad, M. J. Pharm. Biomed. Anal. 2000, 21(6), 1243-48.
27. Hermann, M.; Cristensen, H.; Rebseat, J. L. Anal. Bioanal. Chem. 2004, 382, 1242.
28. Vijaya, S. S.; Devala, R. G.; Bhargav, P. S. K.; Ramana, B.; Manikanta, K. R.; Povan, K. G. Biosci. Biotech. Res. Asia2007, 4(2), 821-22.
29. Stanisz, B.; Rafa, W. Chem. Analityczna 2008, 53(3), 417-28.
30. Kumar, T. R.; Shitut, N. R.; Kumar, P. K.; Vinu, M. C.; Kumar, V. V.; Mullangi, R.; Srinivas, N. R. Biomed. Chromatogr. 2006, 20(9), 881-7.
31. Lan, K.; Jiang, X.; Wang, L.; Zhou, J.; Jiang, Q.; Ye, L. J. Pharm. Biomed. Anal. 2007, 44(2), 540-546.
32. Chaudhari, B. G. ; Patel, N. M. ; Shah, P. B. Indian J. Pharm. Sci. 2007, 69, 130-2.
33. Sahu, R.; Patel, V. B. Indian J. Pharm. Sci. 2007, 69(1), 110-111.
34. Riahi, S.; Ganjali, M. R.; Pourbasheer, E. N. Curr. Pharm. Anal. 2007, 3(4), 268-272.
35. Nagaraj, V. K.; Rajshree, M. Anal. Sci. 2007, 23(4), 445-451.
36. Shirkhedkar, A. A.; Surana, S. J. Biosci. Biotech. Res. Asia 2008, 5(1), 473-476.
37. Sivakumar, T.; Manavalan, R.; Muralidharan, C.; Valliappan, K. J. Sep. Sci. 2007, 30(18), 3143-53.
38. Seshachalam, U.; Kothapally, C. B. J. Liq. Chromatogr. Relat. Tech. 2008, 31(5), 714-21.
39. Vittal, S.; Shitut, N. R.; Kumar, T. R.; Vinu, M. C.;Mullangi, R.; Srinivas, N. R. Biomed. Chromatogr. 2006, 20(11), 1252-9.
40. International Conference on the Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Q2B. Validation of Analytical Procedures, Methodology, 1996.